Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 574.47M P/E - EPS this Y 35.30% Ern Qtrly Grth -
Income -31.63M Forward P/E -39.81 EPS next Y -6.50% 50D Avg Chg 28.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 14.94 EPS next 5Y - 52W High Chg -47.00%
Recommedations 1.80 Quick Ratio 24.50 Shares Outstanding 29.75M 52W Low Chg 92.00%
Insider Own 59.01% ROA -28.50% Shares Float 11.21M Beta -
Inst Own 0.79% ROE -47.95% Shares Shorted/Prior 34.01K/59.47K Price 21.10
Gross Margin - Profit Margin - Avg. Volume 56,703 Target Price 56.50
Oper. Margin - Earnings Date - Volume 31,708 Change -3.26%
About Belite Bio, Inc

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.

Belite Bio, Inc News
05/01/24 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
04/25/24 Belite Bio Announces $25 Million Registered Direct Offering
04/10/24 Does Belite Bio (BLTE) Have the Potential to Rally 41.14% as Wall Street Analysts Expect?
03/22/24 Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
03/20/24 Here's Why We're Not Too Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
03/11/24 Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
03/11/24 Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
03/06/24 Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
03/04/24 Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
02/07/24 Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
01/09/24 Is There An Opportunity With Belite Bio, Inc's (NASDAQ:BLTE) 49% Undervaluation?
11/30/23 Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
11/20/23 Belite Bio to Participate in the BTIG Ophthalmology Day
11/13/23 Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
11/10/23 Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
11/07/23 Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
11/06/23 Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023
11/06/23 Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting
11/01/23 International companies to host live webcasts at Deutsche Bank’s Depositary Receipts
10/31/23 International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 8th and 9th, 2023
BLTE Chatroom

User Image FlynancialAnalyst Posted - 2 days ago

If you $BLTE it they will come! ATHs on deck

User Image Stock_Titan Posted - 4 days ago

$BLTE Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting https://www.stocktitan.net/news/BLTE/belite-bio-announces-presentation-at-the-association-for-research-in-rd3jg8l81g5t.html

User Image FlynancialAnalyst Posted - 04/26/24

A lot of these $NAMS are $BLTE different!

User Image Stock_Titan Posted - 04/25/24

$BLTE Belite Bio Announces $25 Million Registered Direct Offering https://www.stocktitan.net/news/BLTE/belite-bio-announces-25-million-registered-direct-9ywb2pznb3et.html

User Image Stocksrunner Posted - 04/17/24

Warren Buffett's advice to be greedy when others are fearful applies to $ARGX $BLTE and $OLK Technical analysis shows these stocks are in oversold territory, which could present a buying opportunity for risk-tolerant investors.

User Image FlynancialAnalyst Posted - 03/26/24

This mkt is $BLTE different, so it should be ok to accumulate multiple $NAMS in the biotech space. Just don't get $INZY and $CNTA the 5 min chart. And use appropriate size. #WalkTheHill

User Image Stock_Titan Posted - 03/22/24

$BLTE Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan https://www.stocktitan.net/news/BLTE/belite-bio-announces-pmda-submission-of-tinlarebant-for-stargardt-hw74ma9w11r5.html

User Image FlynancialAnalyst Posted - 03/19/24

If this tape $AXSM tape is really $BLTE different, then this is roughly where you'd expect to see buyers step in to support biotech $XBI $IWM $NAMS Other favs: IRON, IDYA, BPMC, BEAM, ARKG, CRNX, RCKT, IMCR ACLX, CNTA,

User Image DonCorleone77 Posted - 03/12/24

$BLTE Belite Bio reports Q4 EPS (27c), consensus (30c) As of December 31, 2023, the Company had $88.2M in cash, as compared with $42.1M on December 31, 2022. "2023 was a productive year for Belite, from the initiation of our Phase III trial in GA, enrollment completion of our Phase III Stargardt disease trial, to the exciting 24-month data from our Phase II Stargardt disease trial," said Dr. Tom Lin, chairman and CEO of Belite Bio. "These milestones continue to underscore the therapeutic potential of Tinlarebant, not only in Stargardt disease, for which there is still no approved treatment, but for patients suffering from GA, for which an oral treatment would be game changing. As we enter 2024, we remain focused on our mission to develop oral therapies for eye diseases with significant unmet medical needs and are well positioned to execute with our strong balance sheet. We expect to share additional analysis from our Phase 2 Stargardt disease trial at the annual meeting...."

User Image DailyStocksPicks Posted - 03/11/24

Today’s pick number two is $AMLX. Amylyx has been experiencing significant volatility and a sharp decline in price, mainly due to the failure of its late-stage ALS trial for the drug Relyvrio. This event has caused regarding the future of the drug's market availability, leading the company to pause all promotions of Relyvrio. The fallout from this development has had a profound impact on investor sentiment and the stock's valuation, contributing to the perception of it being oversold. $SAGE, $MNKD, $MGNX, $BLTE For more details: https://www.youtube.com/watch?v=U0wX3NK-WYw

User Image Stock_Titan Posted - 03/11/24

$BLTE Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website https://www.stocktitan.net/news/BLTE/belite-bio-announces-availability-of-annual-report-on-form-20-f-ukapkrmsyiqj.html

User Image Stock_Titan Posted - 03/11/24

$BLTE Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/BLTE/belite-bio-reports-fourth-quarter-and-full-year-2023-financial-71z69tkdnlkl.html

User Image Stock_Titan Posted - 03/06/24

$BLTE Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results https://www.stocktitan.net/news/BLTE/belite-bio-to-host-webcast-on-march-12-2024-to-discuss-fourth-rzzr6rxbb5tp.html

User Image Stock_Titan Posted - 2 months ago

$BLTE Belite Bio to Participate in the Leerink Partners Global Biopharma Conference https://www.stocktitan.net/news/BLTE/belite-bio-to-participate-in-the-leerink-partners-global-biopharma-wjgkrtmye5u1.html

User Image Doozio Posted - 02/09/24

$BLTE 🧠👀 is now 🧠⏰. Barring a faatch 💣

User Image Stock_Titan Posted - 02/07/24

$BLTE Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference https://www.stocktitan.net/news/BLTE/belite-bio-to-present-at-the-oppenheimer-34th-annual-healthcare-life-4ol661lem160.html

User Image StockInvest_us Posted - 2 months ago

Signal alert: $BLTE - Double Top https://stockinvest.us/l/EDF2gyidxb

User Image FlynancialAnalyst Posted - 3 months ago

$BLTE $1.25B mc $XBI leader looks ready for a breakout to $60. Refusing to close below 10 wk SMA, monster ramp on Friday off the lows, accumulation wk FOUNDER led, 64.03% insider owned. Low short float % for a bio, 0.57%. Only 201 watchers on Stocktwits... #BuiltDifferent 📈💯

User Image StockInvest_us Posted - 3 months ago

Signal alert: $BLTE - Double Top https://stockinvest.us/l/MddNJjGAWR

User Image VirmoMopire Posted - 01/30/24

$BLTE Just spotted some interesting activity on this one. 🧐

User Image StockInvest_us Posted - 01/29/24

Signal alert: $BLTE - Double Top https://stockinvest.us/l/hz7jFgnVZv

User Image StockInvest_us Posted - 01/27/24

Signal alert: $BLTE - Double Top https://stockinvest.us/l/gK6JhYIxTp

User Image StockInvest_us Posted - 01/24/24

Signal alert: $BLTE - Double Top https://stockinvest.us/l/4Gd9uQLn25

User Image StockInvest_us Posted - 01/22/24

Signal alert: $BLTE - Double Top https://stockinvest.us/l/m5LPutl7r1

User Image FlynancialAnalyst Posted - 01/21/24

Would love to make some low-risk high-conviction entries in fav names that are $BLTE different. $CRNX $IDYA $IMCR $KRYS IRON

User Image StockAutomatePro Posted - 01/12/24

$BLTE The chart is pointing towards a possible surge in the stock price. We alerted the BUY signal at $40.51 and we were able to close this one with profit at $45.75 ✅

User Image StockAutomatePro Posted - 01/11/24

$BLTE Stock is headed for a rally according to the chart. We alerted the BUY signal at $40.51 and we were able to close this one with profit at $45.69 💯 See more details at StockAutomate.com

User Image StockAutomatePro Posted - 01/08/24

$BLTE Stock market is looking optimistic based on the chart. We alerted the BUY signal at $40.31 and we were able to close this one with profit at $45.59 🎯

User Image UltraAlgo Posted - 01/08/24

$BLTE Buy Rating based off 4 signals, 15-min chart. 💸 Algo Trading at UltraAlgo https://i.redd.it/6dfh32rpwgac1.png

User Image FlynancialAnalyst Posted - 4 months ago

If this mkt is truly $BLTE different now, then we should see pivot retests of 10 wk SMAs and key levels of support hold w/ ease

Analyst Ratings
HC Wainwright & Co. Buy Mar 22, 24
HC Wainwright & Co. Buy Mar 13, 24
HC Wainwright & Co. Buy Dec 27, 23
Maxim Group Buy Dec 14, 23
HC Wainwright & Co. Buy Nov 15, 23
Benchmark Buy Nov 7, 23
HC Wainwright & Co. Buy Nov 6, 23
HC Wainwright & Co. Buy Aug 10, 23
Cantor Fitzgerald Overweight Jul 28, 23